文献速递烧伤创面修复显微修复重建

分期生物可降解临时基质联合Meek微移植作为大面积烧伤供区节约策略

Staged Biodegradable Temporizing Matrix and Meek Micrografting as a Donor-Sparing Strategy for Extensive Burn Injuries.
PubMed 文献 · J Burn Care Res · 2026-08-08

回顾性分析12例烧伤面积≥50%TBSA成人患者,采用BTM后行Meek微移植完成确定性创面闭合。平均年龄41.5岁,平均烧伤面积63.1%TBSA,平均Baux评分104.6。BTM平均入院后13.3天应用,Meek微移植平均42.2天,Meek覆盖平均32.5%TBSA(占烧伤面积50.6%),手术效率从每1%TBSA覆盖15.2分钟改善至约10.8分钟,可评估病例Meek移植成活率>90%,无患者需二次自体移植,11/12存活至出院或住院康复。

要点

  • BTM联合Meek微移植可用于≥50%TBSA大面积烧伤的确定性创面闭合
  • 该策略允许优先处理特殊区域并等待供区恢复,实现供区节约
  • 研究期间手术效率从每1%TBSA覆盖15.2分钟改善至约10.8分钟

核心结论

  • 分期BTM后行Meek微移植是大面积烧伤确定性闭合的可行供区节约策略,允许特殊区域优先、供区恢复及高效覆盖大面积准备创面。

研究设计与样本

  • 回顾性研究,纳入2022年5月至2025年5月收治的12例烧伤面积≥50%TBSA成人患者,均接受BTM应用后Meek微移植作为确定性创面闭合管理的一部分。

主要发现

  • 12例患者平均年龄41.5岁,平均烧伤面积63.1%TBSA,平均Baux评分104.6,全部有吸入性损伤并需气管切开。
  • BTM平均入院后13.3天应用,Meek微移植平均42.2天进行,Meek覆盖平均32.5%TBSA(占烧伤面积50.6%)。
  • 手术效率从每1%TBSA覆盖15.2分钟改善至约10.8分钟。
  • 可评估病例临床记录的Meek移植成活率>90%,无患者需对Meek移植的BTM区域二次自体移植,11/12存活至出院或住院康复。

临床怎么用

  • 对≥50%TBSA大面积烧伤、供区有限的患者,可考虑分期应用BTM稳定切除创面、待供区恢复后行Meek微移植实现确定性闭合。
  • 该策略可优先处理特殊区域,并利用Meek微移植的受控扩展高效覆盖大面积准备创面。

局限性

  • 回顾性研究,样本量小(12例),无对照组,结果需更大样本前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Definitive closure of extensive burns remains constrained by donor-site availability, particularly in patients with burns of 50% total body surface area (TBSA) or greater. Biodegradable Temporizing Matrix (BTM) can stabilize excised wounds while donor sites recover, whereas Meek micrografting permits controlled expansion of limited autologous skin. We retrospectively reviewed adult patients admitted between May 2022 and May 2025 with burns of 50% TBSA or greater who underwent BTM application followed by Meek micrografting as part of definitive wound-closure management. Demographic, injury, operative, and outcome variables were collected from electronic medical records, operative reports, anesthesia records, wound-care documentation, and clinical photography when available. Twelve patients were included. Mean age was 41.5 years, mean burn size was 63.1% TBSA, and mean Baux score was 104.6. All patients had inhalation injury and required tracheostomy. BTM was applied at a mean of 13.3 days after admission, and Meek micrografting was performed at a mean of 42.2 days. Mean TBSA covered by Meek micrografting was 32.5%, representing 50.6% of the burn surface. Operative efficiency improved from 15.2 to approximately 10.8 minutes per 1% TBSA covered over the study period. Clinically documented Meek graft take exceeded 90% in evaluable cases, no patient required secondary autografting of Meek-grafted BTM areas, and 11 of 12 survived to discharge or inpatient rehabilitation. Staged BTM followed by Meek micrografting is a feasible donor-sparing strategy for extensive burn closure that permits special-area prioritization, donor-site recovery, and efficient definitive coverage of large prepared wound surfaces.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Wise J, Wallace DL, Mason SA, et al. Staged Biodegradable Temporizing Matrix and Meek Micrografting as a Donor-Sparing Strategy for Extensive Burn Injuries. J Burn Care Res. 2026. PMID: 42570311. doi:10.1093/jbcr/irag128

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。